Journal
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
Volume 21, Issue 3, Pages 137-146Publisher
MARY ANN LIEBERT, INC
DOI: 10.1089/107999001750133131
Keywords
-
Ask authors/readers for more resources
Chlamydia pneumoniae has been demonstrated in the cerebrospinal fluid (CSF) of patients with multiple sclerosis (MS), Interferon-beta (IFN-beta) has favorable effects on the clinical course of MS. We investigated whether the beneficial effects of IFN-beta in MS may involve its role in regulating nitric oxide (NO) and interleukin-12 (IL-12) in macrophages, as these immune modulators form part of the innate immune response to intracellular pathogens, such as C, pneumoniae, Murine macrophages in cultures exposed to elementary body antigens or recombinant major outer membrane protein (rMOMP) of C, pneumoniae demonstrate a significant increase in NO as well as production of IL-12/p40 in culture supernatants compared with basal levels, Addition of murine IFN-beta increased NO activity in murine macrophages cultured with chlamydial antigens, Addition of neutralizing anti-IFN-beta antibody prevented the NO increase. In contrast to its effect on inducible NO synthase (iNOS), IFN-beta reduced induction of IL-12/p40 following culture with either elementary body antigens or rMOMP, Inhibition was reversed with anti-IFN-beta antibody. If C, pneumoniae infection is responsible for the inflammatory response in the pathogenesis of MS, the beneficial effects of IFN-beta in MS may be due to its enhancing intracellular NO activity while inhibiting secretion of the proinflammatory cytokine, IL-12.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available